RxLive, a St.Petersburg, FL-based provider of population health pharmacy solutions, raised $5M in Series A funding.
The round was led by SpringTide, with participation by Cardinal Health (NYSE: CAH).
The company, which has raised a total of $8 million to date, intends to use the funds to expand its engineering, analytics, and sales and marketing teams, and invest in the continuous improvement of its AI and the functionality of its medication management platform.
Founded in 2018, RxLive provides an AI powered medication management software, telepharmacy services, and a population health pharmacy analytics platform. The company serves a national customer base of healthcare providers.
FiNSMEs
28/07/2022